Vetoquinol SA Logo

Vetoquinol SA

Develops and markets veterinary medicines for companion animals and livestock.

VETO | PA

Overview

Corporate Details

ISIN(s):
FR0004186856
LEI:
969500YP0AETQIK48R39
Country:
France
Address:
Village, 70200 MAGNY-VERNOIS

Description

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-09-15 17:50
Inside Information / News release on accounts, results
English PDF 757.2 KB
2022-07-20 17:45
Informations privilégiées / Autres communiqués
French PDF 721.1 KB
2022-07-20 17:45
Inside Information / Other news releases
English PDF 727.9 KB
2022-04-22 17:45
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
French PDF 474.4 KB
2022-04-22 17:45
Annual financial and audit reports / Terms of availability of the annual financ…
English PDF 469.4 KB
2022-04-22 08:54
DOCUMENT D'ENREGISTREMENT UNIVERSEL 2021
French ZIP 12.0 MB
2022-04-22 08:54
DOCUMENT D'ENREGISTREMENT UNIVERSEL 2021
French ZIP 12.0 MB
2022-04-13 17:45
Information financière trimestrielle / Information financière du premier trimes…
French PDF 718.4 KB
2022-04-13 17:45
Quarterly financial reporting / First quarter financial report
English PDF 715.6 KB
2022-03-24 07:30
Informations privilégiées / Communiqué sur comptes, résultats
French PDF 763.6 KB
2022-03-24 07:30
Inside Information / News release on accounts, results
English PDF 774.3 KB
2022-01-20 19:45
Inside Information / Information on annual revenues
English PDF 754.6 KB
2022-01-20 19:45
Informations privilégiées / Information sur chiffre d’affaires annuel
French PDF 760.9 KB
2021-12-15 17:50
Informations privilégiées / Autres communiqués
French PDF 457.8 KB
2021-12-15 17:50
Inside Information / Other news releases
English PDF 452.2 KB

Automate Your Workflow. Get a real-time feed of all Vetoquinol SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vetoquinol SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vetoquinol SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-25 N/A Other Sell 4,000 399,600.00 EUR
2024-07-25 N/A Other Buy 4,000 399,600.00 EUR
2024-03-21 N/A Other Sell 3,500 346,500.00 EUR
2024-03-21 N/A Other Buy 3,500 346,500.00 EUR
2024-01-03 N/A Other Buy 1,800 182,880.00 EUR
2023-11-16 N/A Other Buy 1,000 87,500.00 EUR
2023-11-13 N/A Other Sell 1,000 87,500.00 EUR
2023-09-08 N/A Other Buy 400 33,960.00 EUR

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.